ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 770

Integrating Analysis of Skin RNA in Situ Hybridization Using Rnascope and Whole Skin Gene Expression in Systemic Sclerosis Skin to Localize Key Pathogenic Drivers of Skin Fibrosis

Corrado Campochiaro1, Emma C. Derrett-Smith1, Voon H. Ong2, Gail Pearse3, Katherine Nevin3, Shaun Flint3, Mary Morse3, Nicolas Wisniacki4 and Christopher Denton5, 1Centre for Rheumatology and Connective Tissue Diseases, UCL Division of Medicine, London, United Kingdom, 2Rheumatology, UCL Division of Medicine, London, United Kingdom, 3GlaxoSmithKline, Stevenage, United Kingdom, 4ImmunoImflammation, GlaxoSmithKline, Stevenage, United Kingdom, 5Department of Rheumatology, University College London, Royal Free Hospital, London, United Kingdom

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Gene Expression, RNA, Scleredema and skin fibrosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Skin gene expression profiling can distinguish SSc from normal skin and can detect different subsets of disease. Previous studies have reported a cross-sectional relationship between the expression of genes in whole skin and the modified Rodnan skin score (mRSS). We aim to compare gene expression in early versus late dcSSc and define cells responsible for the upregulation of candidate genes.

Methods: Total RNA was extracted from forearm skin biopsies of 3 early dcSSc anti-RNA polymerase III positive (ARA+) patients and 3 late dcSSc ARA+ patients. COMP, chemokine ligand 2 (CCL2), PDGF-A, collagen type I a 1 chain (COL1A1), interferon Induced Protein 44 (IFI44), IL-6, MMP3, SERPINE, TGF-b and thrombospondin 1 (THBS1) was measured using quantitative PCR analysis. mRSS was assessed in all patients and correlated with normalized gene expression. RNA in situ hybridization for a-actin-2 (ACTA2), CCL2, COL1A1, COL3A1, COMP, SERPINE and THBS1 mRNA was performed using RNAscope¨ 2.5 LS Reagent Kit in early dcSSc ARA+ patients (n=2) and healthy controls (HC) (n=3). Semi-quantitative scoring criteria were applied (score from 0 to 4).

Results: Whole skin relative normalized gene expression of COMP, CCL2, IL-6, SERPINE and THBS1 was significantly (p < 0.05) higher in early compared to late SSc skin (COMP mean 25049.15 ± 10862.16 vs 5256.47 ± 2380.53; CCL2 mean 1722.04 ± 598.93 vs 638.25 ± 279.96; IL-6 mean 43.98 ± 40.76 vs 11.91 ± 5.44; SERPINE mean 1770.32 ± 704.46 vs 184.48 ± 61.37; THBS1 mean 7190.75 ± 309.89 vs 1176.81 ± 235.35) [Figure 1]. There was a positive correlation between SERPINE and THBS1 and mRSS (SERPINE r2 = 0.493, p = 0.09; THBS1 r2 = 0.91, p = 0.02). Whole skin relative normalized gene expression of all the remaining genes, except for IFI44, was also higher in early compared to late patients although not significantly.  RNAscope analysis revealed positive SERPINE staining in subsets of fibroblast-like cells located in the mid-dermis in early dcSSc only (score 3 and 4 in early dcSSc vs score 0 in HCs). An increased number of THBS1+ and COMP+ fibroblast-like cells (α-smooth muscle actin +)  were found in the deep dermis of early dcSSc (score 4 in early dcSSc pts vs score 0, 2 and 3 in HCs).

Conclusion: SERPINE, THBS1, COMP, CCL2 and IL-6 are upregulated in early compared to late dcSSc patients. THBS1 and COMP are key genes associated with skin involvement and both are TGF-b regulated. RNAscope technology not only confirmed the upregulation of SERPINE, COMP and THBS1 in early dcSSc, but detected the expression of these genes in the dermis of patients in subsets of cells. These findings highlight how specific cells may be responsible for the pro-fibrotic and inflammatory changes typical of the early stages of the disease. Upregulation of fundamental pro-fibrotic and inflammatory genes could be crucial in the early stages of SSc and specific subsets of cells in the dermis could be the responsible for this. 


Disclosure: C. Campochiaro, None; E. C. Derrett-Smith, None; V. H. Ong, None; G. Pearse, GlaxoSmithKline, 3,GlaxoSmithKline, 1; K. Nevin, GlaxoSmithKline, 3,GlaxoSmithKline, 1; S. Flint, GlaxoSmithKline, 3,GlaxoSmithKline, 1; M. Morse, GlaxoSmithKline, 3,GlaxoSmithKline, 1; N. Wisniacki, GlaxoSmithKline, 1,GlaxoSmithKline, 3; C. Denton, Actelion, Pfizer, GlaxoSmithKline, Bayer, Sanofi-Aventis, Boehringer Ingelheim, Genentech-Roche, CSL Behring, Biogen, 5,Actelion, GlaxoSmithKline, Bayer, Genentech-Roche, CSL Behring, 2.

To cite this abstract in AMA style:

Campochiaro C, Derrett-Smith EC, Ong VH, Pearse G, Nevin K, Flint S, Morse M, Wisniacki N, Denton C. Integrating Analysis of Skin RNA in Situ Hybridization Using Rnascope and Whole Skin Gene Expression in Systemic Sclerosis Skin to Localize Key Pathogenic Drivers of Skin Fibrosis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/integrating-analysis-of-skin-rna-in-situ-hybridization-using-rnascope-and-whole-skin-gene-expression-in-systemic-sclerosis-skin-to-localize-key-pathogenic-drivers-of-skin-fibrosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/integrating-analysis-of-skin-rna-in-situ-hybridization-using-rnascope-and-whole-skin-gene-expression-in-systemic-sclerosis-skin-to-localize-key-pathogenic-drivers-of-skin-fibrosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology